Sheng Xia
- Immunology top 5%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 11
- Immunotherapy and Immune Responses 10
- Immune Response and Inflammation 8
- Immune cells in cancer 8
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Molecular Biology top 10%
- Oncology top 10%
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases 5
-
- Neonatal Respiratory Health Research 10
Sheng Xia
93 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 115
- Immunology 738
- Cancer Research 262
- Molecular Biology 992
- Oncology 319
- Epidemiology 350
Countries citing papers authored by Sheng Xia
This map shows the geographic impact of Sheng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Xia more than expected).
Fields of papers citing papers by Sheng Xia
This network shows the impact of papers produced by Sheng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Xia. The network helps show where Sheng Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 76 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 17 | |
| 12 | 2019 | 4 | |
| 13 | 2017 | 6 | |
| 14 | 2017 | 83 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 32 | |
| 17 | 2016 | 12 | |
| 18 | 2014 | 5 | |
| 19 | 2010 | 1 | |
| 20 | 2005 | 6 |
About Sheng Xia
Sheng Xia is a scholar working on Immunology, Cancer Research, Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 98 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers), Neonatal Respiratory Health Research (10 papers), Immunotherapy and Immune Responses (10 papers), Immune Response and Inflammation (8 papers), Immune cells in cancer (8 papers), MicroRNA in disease regulation (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Immunology (738 citations), Cancer Research (262 citations), Molecular Biology (992 citations), Oncology (319 citations) and Epidemiology (350 citations). Sheng Xia has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Ling Qi, Qixiang Shao, Zhenhong Guo, Xuetao Cao, Xiongfei Xu, Yewei Ji, Rong Li, Shengyi Sun, Xiaogang Li and Teri Johnson. Their work appears in journals such as Scandinavian Journal of Immunology, Clinical & Experimental Immunology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Journal of Cellular Biochemistry and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.